Science Explorer Interactive view Map
Company · Somerset · United States

Vifor Pharma (United States)

viforpharma.comROR OpenAlex
World rank, all time
#28,940
of 42,892
Rank in United States
#6,194
of 8,685
Research works
185
▲ 49% vs 2013–17
Citations
3.7k
20.2 per fractional work
Top-10% rate
17.0%
record average 16.5%
Open access
45%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.38× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.86× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 4.63× its world share, 3 worksImmunology and Micro…Neuroscience: 0.30× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.91× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.83× its world share, 3 worksChemistryComputer Science: 0.35× its world share, 2 worksComputer ScienceEngineering: 0.20× its world share, 2 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.45× its world share, 1 worksMaterials ScienceHealth Professions: 0.18× its world share, 0 worksHealth ProfessionsMedicine: 2.54× its world share, 28 worksMedicineNursing: 5.15× its world share, 2 worksNursingVeterinary: 0.84× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 1.11× its world share, 2 worksBusiness, Management…Economics, Econometrics and Finance: 2.70× its world share, 3 worksEconomics, Econometr…Psychology: 0.19× its world share, 0 worksPsychologySocial Sciences: 0.17× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 5.2×. Every wedge is a field page.

Which keywords describe research at Vifor Pharma (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chronic Kidney Disease, Inflammation, Heart Failure, Cancer Therapy, Immunotherapy, Oxidative Stress, Cardiovascular Disease and Anemia.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation5▲ 3.8×18 topics
  2. Epidemiology4▲ 1.53×18 topics
  3. Chronic Kidney Disease3▲ 23×5 topics
  4. Oxidative Stress3▲ 3.5×11 topics
  5. Heart Failure3▲ 13×4 topics
  6. Cancer Therapy3▲ 8.7×14 topics
  7. Cardiovascular Disease3▲ 4.4×9 topics
  8. Immunotherapy3▲ 6.5×10 topics
  9. Quality of Life2▲ 2.6×6 topics
  10. Anemia2▲ 38×2 topics
  11. Iron Deficiency2▲ 70×2 topics
  12. Nanoparticles2▲ 2.6×6 topics
  13. Clinical Trials2▲ 4.6×8 topics
  14. Hyperkalemia2▲ 211×1 topic
  15. Neuroprotection2▲ 8.8×3 topics
  16. Renin-Angiotensin-Aldosterone System Inhibitors2▲ 211×1 topic
  17. Neurological Disorders2▲ 5.2×5 topics
  18. Prognostic Factors2▲ 6.7×7 topics
  19. Immune Response2▲ 4.9×8 topics
  20. Rituximab2▲ 18×3 topics
  21. Tumor Targeting2▲ 16×3 topics
  22. Drug Delivery2▲ 4.8×3 topics
  23. Lymphoma1▲ 15×2 topics
  24. Nutrition1▲ 5.2×4 topics
  25. Hepcidin1▲ 58×1 topic
  26. Iron Regulation1▲ 58×1 topic
  27. Toxicity1▲ 5.1×3 topics
  28. Tumor Regression1▲ 20×2 topics
  29. Cancer Immunotherapy1▲ 14×2 topics
  30. Cancer Treatment1▲ 9.2×4 topics
  31. Cost-effectiveness Analysis1▲ 25×1 topic
  32. Drug Development Costs1▲ 79×1 topic
  33. Generic Drugs1▲ 79×1 topic
  34. Health Utility Measures1▲ 25×1 topic
  35. Immune Dysregulation1▲ 26×2 topics
  36. Vaccine1▲ 5.3×4 topics
  37. Cell Death1▲ 8.4×5 topics
  38. Filaggrin1▲ 40×1 topic
  39. Skin Microbiome1▲ 40×1 topic
  40. Gene Therapy1▲ 9.4×4 topics

Which research topics does Vifor Pharma (United States) publish most on?

By volume in 2022–2025: Potassium and Related Disorders, Iron Metabolism and Disorders, Pharmaceutical Economics and Policy and Health Systems, Economic Evaluations, Quality of Life.

Potassium and Related Di…2Potassium and Related Disorders: 2 fractional worksIron Metabolism and Diso…1Iron Metabolism and Disorders: 1 fractional worksPharmaceutical Economics and Policy: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksDermatology and Skin Diseases: 1 fractional worksCAR-T cell therapy research: 1 fractional worksCOVID-19 diagnosis using AI: 1 fractional worksInnovation and Socioecon…1Innovation and Socioeconomic Development: 1 fractional worksHemoglobinopathies and Related Disorders: 1 fractional worksErythropoietin and Anemia Treatment: 1 fractional works
Pulmonary and Respiratory MedicineHematologyEconomics and EconometricsDermatology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Potassium and Related Disorders Pulmonary and Respiratory Medicine 2 works
  2. 2 Iron Metabolism and Disorders Hematology 1 works
  3. 3 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  4. 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  5. 5 Dermatology and Skin Diseases Dermatology 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 COVID-19 diagnosis using AI Radiology, Nuclear Medicine and Imaging 1 works
  8. 8 Innovation and Socioeconomic Development Business and International Management 1 works
  9. 9 Hemoglobinopathies and Related Disorders Genetics 1 works
  10. 10 Erythropoietin and Anemia Treatment Hematology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.6%not open55.4%

World: 28% of research is openly available.

with international co-authors39.1%domestic only60.9%

World: 19% is written across borders.

How has Vifor Pharma (United States)'s research output changed?

Output in 2018–2022 was 49% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Somerset

All research institutions in Somerset

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.